Primary endpoint met of HAM-A scores at week 4 met in phase 2b MMED008 study, when Generalized Anxiety Disorder patients were given MM-120. 12-week HAM-A results from phase 2b MMED008 study in GAD to ...
Philadelphia, PA, May 21, 2002 –Venlafaxine HCl is a significantly effective and well-tolerated treatment for children and adolescents who have generalized anxiety disorder (GAD), according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback